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ABSTRACT
The protein–ligand interacting mechanism is essen-
tial to biological processes and drug discovery. The
SiMMap server statistically derives site-moiety map
with several anchors, which describe the relation-
ship between the moiety preferences and physico-
chemical properties of the binding site, from the
interaction profiles between query target protein
and its docked (or co-crystallized) compounds.
Each anchor includes three basic elements: a
binding pocket with conserved interacting
residues, the moiety composition of query com-
pounds and pocket–moiety interaction type (electro-
static, hydrogen bonding or van der Waals). We
provide initial validation of the site-moiety map on
three targets, thymidine kinase, and estrogen recep-
tors of antagonists and agonists. Experimental
results show that an anchor is often a hot spot
and the site-moiety map can help to assemble po-
tential leads by optimal steric, hydrogen bonding
and electronic moieties. When a compound highly
agrees with anchors of site-moiety map, this
compound often activates or inhibits the target
protein. We believe that the site-moiety map is
useful for drug discovery and understanding bio-
logical mechanisms. The SiMMap web server is
available at http://simfam.life.nctu.edu.tw/.
INTRODUCTION
As the number of protein structures increases rapidly,
structure-based drug design and virtual screening
approaches are becoming important and helpful in
lead discovery (1–4). A number of docking and
virtual screening methods (5–8) have been utilized to
indentify lead compounds, and some success stories
have been reported (9–13). However, identifying lead
compounds by exploiting thousands of docked protein–
compound complexes is still a challenging task. The
major weakness of virtual screenings is likely due to
incomplete understandings of ligand-binding mecha-
nisms and the subsequently imprecise scoring algorithms
(2–4).
Most of docking programs (5–7) use energy-based
scoring methods which are often biased toward both the
selection of high-molecular weight compounds and
charged polar compounds (14,15). These approaches gen-
erally cannot identify the key features (e.g. pharmaco-
phore spots) that are essential to trigger or block the
biological responses of the target protein. Although
pharmacophore techniques (16) have been applied to
derive the key features, these methods require a set of
known active ligands that were acquired experimentally.
Therefore, the more powerful techniques for post-
screening analysis to identify the key features through
docked compounds and to understand the binding
mechanisms provide a great potential value for drug
design.
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server to infer the key features by a site-moiety map
describing the relationship between the moiety preferences
and the physico-chemical properties of the binding site.
According to our knowledge, SiMMap is the ﬁrst public
server that identiﬁes the site-moiety map from a query
protein structure and its docked (or co-crystallized) com-
pounds. The server provides pocket–moiety interaction
preferences (anchors) including binding pockets with
conserved interacting residues, moiety preferences and
interaction type. We veriﬁed the site-moiety map on
three targets, thymidine kinase, and estrogen receptors
of antagonists and agonists. Experimental results show
that an anchor is often a hot spot and the site-moiety
map is useful to identify active compounds for these
targets. We believe that the site-moiety map is able to
provide biological insights and is useful for drug discovery
and lead optimization.
METHOD AND IMPLEMENTATION
Figure 1 presents an overview of the SiMMap server for
identifying the site-moiety map with anchors, describing
moiety preferences and physico-chemical properties of the
binding site, from a query protein structure and docked
compounds. The server ﬁrst uses checkmol (http://merian
.pch.univie.ac.at/ nhaider/cheminf/cmmm) to recognize
the compound moieties and utilizes GEMDOCK (8) to
generate a merged protein–compound interaction proﬁle
(Figure 1B), including electrostatic (E), hydrogen bonding
(H) and van der Waals (V) interactions. According to this
proﬁle, we infer anchor candidates by identifying the
pockets with signiﬁcant interacting residues and moieties
with Z-score  1.645. The neighbor anchor candidates,
which are the same interaction type and the distances
between their centers are <3.5A ˚ , are grouped into one
anchor. These anchors form the site-moiety map
describing interaction preferences between compound
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Step 1: Query a target protein 
structure and its docked (co-
crystallized) compounds
Step 2: Generate protein-
compound interaction profiles 
and identify compound 
moieties 
Step 3: Derive an anchor 
candidate by identifying a 
pocket with significant 
interacting residues and 
moieties with Z-score  1.645
Step 4: Determine anchors by 
grouping neighbor anchor 
candidates with same type. For 
each anchor, identify its 
binding pocket, top-significant 
interacting residues, moiety 
preferences, and anchor type
Step 6: Output graphically site-
moiety map; anchors with 
moiety structures and 
compositions; and pocket-
moiety interactions.  
Step 5: Determine site-moiety 
map with anchors and rescore 
compounds
Figure 1. Overview of the SiMMap server for the site-moiety map using herpes simplex virus type-1 thymidine kinase (TK) and 1000 docked
compounds as the query. (A) Main procedure; (B) the merged protein–compound interaction proﬁle; (C) the pocket–moiety interaction preferences of
three anchors: E1 (electrostatic), H2 (hydrogen-bonding) and V1 (van der Waals). Each anchor consists of a binding pocket with conserved
interacting residues, the moiety composition and anchor type; (D) the site-moiety map with four anchors.
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and D). Finally, this server provides graphic visualization
for the site-moiety map; anchors with moiety structures
and compositions, pocket–moiety interactions and the
relationship between anchors and moieties of query
compounds.
Site-moiety map, anchor and pocket
The anchor (pocket–moiety interaction preference) is the
core of a site-moiety map. An anchor possesses three es-
sential elements: (i) a binding pocket with conserved inter-
acting residues and speciﬁc physico-chemical properties;
(ii) moiety preferences of the pocket; (iii) pocket–moiety
interaction type (E, H or V). An anchor can be considered
as ‘key features’ for representing the conserved binding
environment element or a ‘hot spot’ that involves biologic-
al functions. In addition, we regard a binding pocket,
which consists of several residues signiﬁcantly interacting
to compound moieties, as a part of the binding site. The
binding pocket often possesses speciﬁc physico-chemical
properties and geometric shape to bind preferred
moieties. The site-moiety map, which can help to
assemble potential leads by optimal steric, hydrogen
bonding, and electronic moieties, is useful for drug discov-
ery and understanding biological mechanisms.
Data sets
To describe and evaluate the utility of the SiMMap server,
we tested the server on three target proteins for virtual
screening. These proteins are herpes simplex virus type-1
thymidine kinase [TK, PDB code 1kim(17)], estrogen
receptor a for antagonists [ER, PDB code 3ert(18)] and
estrogen receptor a for agonists [ERA, PDB code
1gwr(19)]. Each compound set consists of 10 known
active ligands and 990 compounds selected randomly
from available chemical directory (ACD) proposed by
Bissantz et al. (20). Currently, the docked conformations
of these 1000 compounds were generated by the in-house
GEMDOCK program (8) which is comparable to some
docking methods (e.g. DOCK, FlexX and GOLD) on
the 100 protein–ligand complexes and some screening
targets (8,14). In addition, GEMDOCK has been success-
fully applied to identify inhibitors and binding sites for
some targets (10,13,21,22).
Main procedure
The SiMMap server performs six main steps for a query
(Figure 1A). Here, we used TK as an example for
describing these steps. First, users input a protein struc-
ture and its docked compounds. The server used checkmol
to identify moieties of docked compounds and
GEMDOCK to generate E, H and V interaction
proﬁles. For each proﬁle, the matrix size is N K
where N and K are the numbers of compounds and inter-
acting residues of query protein, respectively. An inter-
action proﬁle matrix P(I) with type I (E, H or V) is
represented as
PðIÞ¼
p1,1 p1,2     p1K
p2,1 p2,2     p2K
. .
. . .
. ..
. . .
.
pN,1 pN,2     pNK
2
6 6 6 4
3
7 7 7 5
where pi,j is a binary value for the compound i interacting
to the residue j (Figure 1B). For H and E proﬁles, pi,j is
set to 1 (green) if an atom pair between the compound i
and the residue j forms hydrogen bonding or electrostatic
interactions, respectively; conversely, the interaction is
set to 0 (black). For van der Waals (vdW) interaction,
an interaction is set to 1 when the energy is less than
 4(kcal/mol).
SiMMap identiﬁed consensus interactions between
residues and compound moieties with similar
physical-chemical properties through the proﬁles. For
each interacting residue [a column of the matrix P(I);
(Figure 1B)], we used Z-score value to measure the inter-
acting conservation between this residue and moieties. The
standard deviation (s) and mean (m) were derived by
random shuﬄing 1000 times in a proﬁle. The Z-score of
the residue j is deﬁned as Zj ¼ fj    = , where fj is the
interaction frequency and given as fj ¼
PN
i¼1
pij
N.
Spatially, neighbor interacting residues and moieties
with statistically signiﬁcant Z-score  1.645 were referred
as an anchor candidate. Neighbor anchor candidates,
which are spatially overlapped and the same anchor
type, were clustered as an anchor and the anchor center
is the weighted geometric center of their interacting
compound moieties. Here, two anchors were merged if
the distance of two anchor centers is <3.5 A ˚ . In each
anchor, top three residues with the highest Z-score
values were regarded as key residues forming a binding
pocket. For each anchor, we identiﬁed its moieties of
docked compounds according to the moiety library
derived from checkmol, and calculated the moiety com-
position (Figure 1C). These anchors form the site-moiety
map (Figure 1D) of the query.
SiMMap can be applied to identify active compounds
for structure-based virtual screening. One of weaknesses
of virtual screening is likely incomplete understanding of
the chemistry involved in ligand binding and the subse-
quently imprecise scoring algorithms. When a compound
highly agrees with the anchors of the site-moiety map, this
compound often activates or inhibits the target. The
SiMMap server scores a compound by combining pre-
dicted binding energy of GEMDOCK and the anchor
score between the map and the compound. The
SiMMap score, S(i), for a compound i is deﬁned as
SðiÞ¼
Xn
a¼1 ASaðiÞ+ð 0:001Þ
EðiÞ
M0:5 ð1Þ
where ASa(i) is the anchor score of compound i in the
anchor a, n is the number of anchors, E(i) is the docked
energy of compound i and M is the atom number of
compound i. The anchor score is set to 1 when the
compound i agrees the moiety preference of the anchor
a. Here, the anchor score and the term M
0.5 are useful
W426 Nucleic Acids Research, 2010,Vol.38, Web Server issueto reduce the deleterious eﬀects of selecting high-
molecular weight compounds (23). Based on SiMMap
scores, we can obtain new ranks of query compounds.
INPUT AND OUTPUT
SiMMap is an easy-to-use web server (Figure 2). Users
input a protein structure without ligands in PDB format
and its docked or co-crystallized compounds in MDL mol,
SYBYL mol2 or PDB format (Figure 2A). These docked
compounds should be generated by any external docking
methods (e.g. DOCK, FlexX, GOLD and GEMDOCK)
before users uploaded these compounds. Typically, the
SiMMap server yields a site-moiety map within 5min if
the number of query compounds is less than 100. This
server provides the graphic visualization of the site-moiety
map and anchors elements, including a binding pocket
with interacting residues, moiety compositions and struc-
tures, numbers of involved compounds, and anchor types
(Figure 2B). For each anchor, this server shows docked
conformations of compounds and the detailed atomic
interactions between pocket residues and moieties
(Figure 2C). In addition, SiMMap shows the new rank
and compound moiety structures ﬁtting the anchors for
each query compound (Figure 2D). SiMMap uses two
open source tools for graphic visualization: Jmol
(http://www.jmol.org/) for displaying 3D protein and
compound structures with anchors and OASA
(http://bkchem.zirael.org/oasa_en.html) for visualizing
compound structures. The server allows users to
download the anchor coordinates in the PDB format;
interaction proﬁles; new ranks and anchor scores of
query compounds.
EXAMPLE ANALYSIS
Thymidine kinase
The SiMMap server inferred the site-moiety map of
TK. This map consisted of four anchors [i.e. E1, H1, H2
and V1 (Figure 1D)] and the moiety composition
and conserved interacting residues of each anchor
(Figure 1C). The E1 anchor possesses a binding pocket
with residue R222, and three moiety types [i.e. sulfuric
Figure 2. The SiMMap server analysis results using estrogen receptor (ER) and 1000 docked compounds as the query. (A) The user interface for
uploading target protein structure and docked compounds. (B) The site-moiety map has one hydrogen-bonding and three van der Waals anchors for
ER. Each anchor contains the moiety structures and composition, anchor type, and key residues in the binding pocket. (C) The details of moiety
structures and residue–moiety interactions in the H1 anchor. (D) The SiMMap scores, ranks and the relationships between anchors and moieties of
query compounds.
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phoric acid monoester (25%)] derived from 57 com-
pounds. The E1 includes the phosphate moiety of ATP
and its residue R222 playing a major role to interact
with the substrate (24,25). Furthermore, the H1 anchor
is a polar pocket with three residues (H58, R222 and
E225) that often form hydrogen bonds with polar
moiety types among 308 compounds, for example,
hydroxyl group (22%), carboxylic acid (8%), ketone
(8%), ether (7%) and carboxylic amide (7%). The H2
anchor consists of the residue Q125 and 157 moieties
divided into ﬁve major moiety types, including hydroxyl
group (38%), carboxylic amide (14%), ketone (9%),
amine (8%) and sulfuric acid monoester (6%). Finally,
the V1 anchor has a binding pocket with residues W88,
R163, Y172 and bulky moieties, such as aromatic ring
(42%), heterocyclic group (23%), phenol (9%) and
oxohetarene (5%).
The preferred moiety types of an anchor are suitable
groups interacting to conserved residues of the binding
pocket. The moiety preference is able to guide the sugges-
tion of functional group substitutions for lead structures.
For example, the moiety preferences of these four anchors
(Figure 1D) cover the moiety types derived from 15 TK
co-crystal ligands (Supplementary Table S1). In addition,
these compounds contain carboxylic amide or amine
groups in the H1 anchor. This result shows that the
pocket–moiety interactions of these 15 complexes are
highly consistent with the pocket–moiety interaction pref-
erences obtained from 1000 docked complexes.
Estrogen receptor
We used estrogen receptor (ER), a therapeutic target for
osteoporosis and breast cancer (26), as the second
example. Based on 1000 docked compounds and ER, the
SiMMap server identiﬁes four anchors (H1, V1, V2 and
V3) and provides moiety preferences and compositions in
these anchors (Figure 2B). The H1 anchor comprises three
residues (E353, L387 and R394) and ﬁve main moiety
types: hydroxyl group (36%), carboxylic acid (16%),
amine (7%), ketone (7%) and sulfuric acid monoester
(6%) summarized from 319 compounds. Furthermore,
three residues (L346, T347 and L525) and 839 compounds
are involved in the V1 anchor, preferring ﬁve moiety types
[i.e. aromatic ring (49%), heterocyclic group (22%),
alkenes (11%), phenol (8%) and oxohetarene (4%)]. The
anchor V2 is a hydrophobic pocket containing L346, F404
and L387, and the former two residues are highly
conserved (27). These hydrophobic residues interact with
aromatic ring (52%), heterocyclic group (23%), phenol
(12%), alkenes (5%) and oxohetarene (3%). Finally,
aromatic rings (55%), heterocyclic groups (17%),
alkenes (11%) and phenols (9%) summarized from 560
compounds often form vdW contacts with the long side
chains of M343, M421 and L525 in the anchor V3. The
ring groups of antagonists are often stabilized by the side
chains of M343, L346, T347, L387, M421 and L525. In
this case, most selective estrogen receptor modulators
of ER [e.g. EST_01 (raloxifene), EST_06 (LY-326315,)
and EST_05 (EM-343)] agree with these four anchors
(Figure 2D).
RESULTS
Anchors identiﬁed by the SiMMap server often contain
key pockets and moieties. To initially validate the
anchors for biological mechanisms (e.g. ligand binding
and catalysis mechanisms), we selected 15 TK and 22
ER co-crystallized ligands (Figure 3, Supplementary
Table S1 and Figure S1). The corresponding moieties of
these co-crystallized ligands were highly matched the an-
chors derived from 1000 docked compounds (10 known
active ligands and 990 randomly selected compounds
described in ‘Data sets’ section). The site-directed muta-
genesis shows that the conserved interacting residues of
the anchors are often essential for ligand binding and ca-
talysis mechanisms. For example, the positive-charged
residue R222 in E1 interacts with the phosphate group
of TK substrates for phosphorylation (28; Figure 3A
and B). The site-directed mutagenesis indicates that
Q125 in H2 is essential for the substrate speciﬁcity (24)
and the triple mutant, H58L/M128F/Y172F (H1 and V1),
shows the drug resistance to the compound acyclovir (29).
In addition, the hydrogen-bonding interaction between
E225 and the hydroxyl group of the substrates is able to
help stabilize the LID region for the catalytic reaction
(29). For ER target, 22 ER co-crystallized ligands
contain three consistent moieties that are hydroxyl
group and aromatic rings (Supplementary Figure S1).
The hydroxyl group forms hydrogen bonds with R394
and E353 in H1, and the aromatic ring yields vdW
contacts with L346, L387 and F404 in V2. The other con-
sistent aromatic ring forms vdW contacts with L346, T347
and L525 in V1. These results show that an anchor is often
a hot spot and involved in biological functions.
To provide initial validation of the SiMMap server for
virtual screening, we selected TK, ER and ERA with 1000
compounds as test sets. First, we compared the accuracies
of SiMMap with those of GEMDOCK on these three
targets based on true positive rates (Supplementary
Figure S2). SiMMap, combining anchor scores and
docking energies (Equation 1), outperforms
GEMDOCK on these cases. We then compared
SiMMap with other three programs (DOCK, FlexX and
GOLD) on TK and ER sets. All approaches were tested
using the same proteins and compound sets
(Supplementary Table S2). When the positive rate was
90%, the false positive rates were 6.8% (SiMMap),
25.5% (DOCK), 13.3% (FlexX) and 9.1% (GOLD) for
TK and were 1.1% (SiMMap), 17.4% (DOCK), 70.9%
(FlexX) and 8.3% (GOLD) for ER.
The compound, which agrees with anchors of the
site-moiety map, is often able to activate or inhibit the
target protein (Supplementary Tables S1, S3 and S4).
In addition, the anchor score [i.e. AS(i) deﬁned in
Equation 1] of SiMMap can be used to reduce the ill-eﬀect
of the energy-based scoring methods which are often
biased toward both the selection of high molecular
weight compounds and charged polar compounds
W428 Nucleic Acids Research, 2010,Vol.38, Web Server issue(14,15). For example, according to the SiMMap scores
(Equation 1), the ranks of MFCD0005750 (adenylic
acid), MFCD0005753 (deoxyadenylic acid) and
MFCD0005763 (30-guanylic acid) are 1, 3 and 9, respect-
ively. These three compounds are thymidine analogs and
agree with the four anchors of TK (Figure 1 and
Supplementary Table S3). For the top ranks of ER,
MFCD0002206 (masoprocol) and MFCD00012748 were
also the analogs of the active compounds (Supplementary
Table S4). The anchor score of SiMMap was helpful to
reduce the highly polar compounds (e.g. MFCD00011393
and MFCD00003569 in TK; MFCD00004690 and
MFCD00013089 in ER) whose anchor scores are low.
The anchor score of SiMMap can easily combine with
other energy-based scoring functions.
CONCLUSION
This work demonstrates the utility and feasibility of the
SiMMap server for statistically inferring the site-moiety
map describing the relationship between the moiety pref-
erences and physico-chemical properties of the binding
site. Our experimental results show that the site-moiety
map is useful to reﬂect biological functions and identify
active compounds from thousands of compounds. In
addition, the site-moiety map can guide to assemble po-
tential leads by optimal steric, hydrogen-bonding, and
electronic moieties. We believe that the SiMMap serve is
able to provide the biological insights of protein–ligand
binding models, enrich the screening accuracy, and guide
the processes of lead optimization.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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